AXIM BIOTECHNOLOGI COM USD0.0001 (AXIM)

9.14
0.56 6.53
OTC
Prev Close 8.58
Open 8.39
Day Low/High 8.15 / 9.14
52 Wk Low/High 0.21 / 19.80
Volume 115.91K
Exchange OTC
Shares Outstanding 51.49B
Market Cap 475.28M
Div & Yield N.A. (N.A)

Latest News

AXIM® Biotech Expands Advisory Board To Broaden The Development Of Cannabinoids' Therapeutic Indications

AXIM® Biotech Expands Advisory Board To Broaden The Development Of Cannabinoids' Therapeutic Indications

Company Continues to Build World Class Advisory Board Including the Addition of Famed Cardiac Anesthesiologist Dr. Emil Engels MD, MBA, CPC

Axim® Biotech Announces Addition Of World-Renowned Opthamologist To Advisory Board

Axim® Biotech Announces Addition Of World-Renowned Opthamologist To Advisory Board

Company Announces Appointment of Top International Glaucoma Expert to Advise Company's Upcoming Cannabinoid Research

New U.S. Patent Allowance Granted To AXIM® Biotech For Use Of All Cannabinoids In Its Controlled-Release Chewing Gum Products

New U.S. Patent Allowance Granted To AXIM® Biotech For Use Of All Cannabinoids In Its Controlled-Release Chewing Gum Products

Allows Award-Winning Cannabinoid Release Chewing Gum Products to be Used as Delivery Mechanism for All Cannabinoids, Including THC, CBD, CBG, etc.

AXIM® Biotechnologies, Inc. Publishes Product Pipeline Chart For Pharmaceutical Clinical Trials Program In Cannabinoid R&D

AXIM® Biotechnologies, Inc. Publishes Product Pipeline Chart For Pharmaceutical Clinical Trials Program In Cannabinoid R&D

Cannabinoid Innovator's Product Pipeline Highlights Timelines of Its Intellectual Property (IP) Protected Cannabinoid-Based Products from Pre-Clinical to NDA for Multiple Indications

AXIM® Biotechnologies, Inc. Secures Funding To Continue Pharmaceutical Clinical Trials Program In Cannabinoid Research And Development For Multiple Indications

AXIM® Biotechnologies, Inc. Secures Funding To Continue Pharmaceutical Clinical Trials Program In Cannabinoid Research And Development For Multiple Indications

Financing Enables Cannabinoid Innovator to Continue Phase I-II Trials Of Numerous Intellectual Property (IP) Protected Cannabinoid-Based Products

AXIM Biotechnologies, Inc. CEO To Speak At First-Ever National Symposium On Medical Cannabis For Healthcare Professionals In Mexico City

AXIM Biotechnologies, Inc. CEO To Speak At First-Ever National Symposium On Medical Cannabis For Healthcare Professionals In Mexico City

AXIM CEO to Discuss Company's Use of Cannabinoids to Treat Health Conditions with No Known Cure at Symposium Held by Medical Marijuana, Inc.'s HempMeds® Mexico

AXIM Biotechnologies, Inc. Increases CanChew Cannabidiol (CBD) Gum Donations By 200%, Beneficiaries Include U.S. Veterans And Legacy Customers

AXIM Biotechnologies, Inc. Increases CanChew Cannabidiol (CBD) Gum Donations By 200%, Beneficiaries Include U.S. Veterans And Legacy Customers

AXIM® Launches Appreciation Program That Benefits U.S. Warfighters, Emphasizes Freedom to Choose Hemp Based Health and Wellness Options, Rewards Long-Term Consumer Use

AXIM Biotech Begins Human Clinical Trials With Cannabigerol (CBG) For Psoriasis And Eczema In Patients

AXIM Biotech Begins Human Clinical Trials With Cannabigerol (CBG) For Psoriasis And Eczema In Patients

AXIM's CBG Clinical Trials Led by World-Renowned Dermatologist and Specialist on Psoriasis and Eczema, Dr. Meinardi, at The Maurits Clinics in The Hague, The Netherlands

AXIM Biotech CEO Appointed To American Pain Association Board Of Advisors, Addresses American Opioid Abuse Epidemic

AXIM Biotech CEO Appointed To American Pain Association Board Of Advisors, Addresses American Opioid Abuse Epidemic

AXIM CEO Joins APA Board of Advisors in Appeal to U.S. Surgeon General About the No. 1 U.S. Health Crisis: Prescription Opioid Abuse Epidemic

AXIM Biotech Leads Cannabis Industry In Cannabinoid Research, Development And Intellectual Property; Tackles 15 Debilitating Conditions With No Known Cure

AXIM Biotech Leads Cannabis Industry In Cannabinoid Research, Development And Intellectual Property; Tackles 15 Debilitating Conditions With No Known Cure

Global Hemp Innovator Unveils Impressive Pipeline of Cannabis-Based Health and Wellness Solutions

AXIM Biotechnologies Expands Executive Team And Advisory Board With Finance And Pro Sports Leaders: Seth Yakatan And Marvin Washington

AXIM Biotechnologies Expands Executive Team And Advisory Board With Finance And Pro Sports Leaders: Seth Yakatan And Marvin Washington

Hemp Industry Innovator, AXIM(R) Biotech, Adds Two Industry Leaders to the Company's Advisory Board: Seth Yakatan - Biotech Finance Consultant; and Marvin Washington - NFL Star and Sports Advisor

AXIM Biotechnologies Secures Land Down Payment For Hemp Life Sciences Manufacturing Site

AXIM Biotechnologies Secures Land Down Payment For Hemp Life Sciences Manufacturing Site

Company's Global Manufacturing Facility Move Forward in Almere, The Netherlands

Photo Release -- AXIM Biotechnologies Adds Health Industry Senior Marketing Executive Joe Grace To Advisory Board

Photo Release -- AXIM Biotechnologies Adds Health Industry Senior Marketing Executive Joe Grace To Advisory Board

Veteran Marketing Executive Who Grew WebMD's Audience to 25 Million Unique Monthly Visitors Brings Decades of Health Industry Experience to AXIM Biotech's Board of Advisors

AXIM Biotech Explains Cannabis Chewing Gum Clinical Trials For Pain And Spasticity With MS, Plans To Enter General Pain Market

AXIM Biotech Explains Cannabis Chewing Gum Clinical Trials For Pain And Spasticity With MS, Plans To Enter General Pain Market

Agricultural Hemp Biotech's Cannabinoid Innovations for Multiple Sclerosis Patients Lead to Entry Into $60 Billion General Pain Market

AXIM Biotech Announces Launch Of Clinical Trials On MedChew RX(TM) And Development Of Pharmaceutical-Grade Cannabis Chewing Gum

AXIM Biotech Announces Launch Of Clinical Trials On MedChew RX(TM) And Development Of Pharmaceutical-Grade Cannabis Chewing Gum

Global Industrial Hemp Bioscience Company Announces Clinical Trials at Free University of Amsterdam, The Netherlands